Growth Metrics

InspireMD (NSPR) Cash & Current Investments (2016 - 2025)

InspireMD's Cash & Current Investments history spans 16 years, with the latest figure at $54.2 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 56.51% year-over-year to $54.2 million; the TTM value through Dec 2025 reached $54.2 million, up 56.51%, while the annual FY2025 figure was $54.2 million, 56.51% up from the prior year.
  • Cash & Current Investments reached $54.2 million in Q4 2025 per NSPR's latest filing, down from $63.4 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $63.4 million in Q3 2025 to a low of $12.9 million in Q1 2023.
  • Average Cash & Current Investments over 5 years is $35.3 million, with a median of $35.9 million recorded in 2021.
  • Peak YoY movement for Cash & Current Investments: surged 1301.91% in 2021, then crashed 58.92% in 2025.
  • A 5-year view of Cash & Current Investments shows it stood at $34.0 million in 2021, then tumbled by 47.7% to $17.8 million in 2022, then skyrocketed by 119.19% to $39.0 million in 2023, then dropped by 11.24% to $34.6 million in 2024, then skyrocketed by 56.51% to $54.2 million in 2025.
  • Per Business Quant, the three most recent readings for NSPR's Cash & Current Investments are $54.2 million (Q4 2025), $63.4 million (Q3 2025), and $19.4 million (Q2 2025).